AIG
AVNR

American International Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

American International Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-122,205
Closed -$2.07M – 5180
2014
Q4 		$2.07M Buy
122,205
+17,514
+17% +$246K 0.01% 1106
2014
Q3 		$1.25M Buy
104,691
+89
+0.1% +$608 0.01% 1393
2014
Q2 		$590K Buy
104,602
+3,881
+4% +$17.9K ﹤0.01% 2031
2014
Q1 		$370K Buy
100,721
+2,369
+2% +$9.03K ﹤0.01% 2314
2013
Q4 		$330K Sell
98,352
-1,467
-1% -$6.06K ﹤0.01% 2345
2013
Q3 		$423K Buy
99,819
+5,817
+6% +$27.6K ﹤0.01% 2095
2013
Q2 		$432K Buy
+94,002
New +$323K ﹤0.01% 1961

American International Group's AVNR Position: Q1 2015 in Review

American International Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 122,205 shares — an estimated $2.07M sold.

American International Group first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $2.07M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • American International Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • American International Group sold 122,205 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.07M.
  • American International Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • American International Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.07M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on American International Group's 13F filing for Q1 2015, filed 14 May 2015.